Författare: Smith J Gustav, Kornhall Björn, Ekmehag Björn

Titel: ABC om kronisk hjärtsvikt, del 1: utredning (serie: Medicinens ABC) 2012 nr 38 sid 1673-7

Läs/ladda hem artikeln:
Fullständig referenslista
Artikeln i pdf-format
Artikeln i webbversion
Sid 1673
Sid 1674
Sid 1675
Sid 1676
Sid 1677
Om Läkartidningens fulltext på Internet
Kronisk sjukdom
Kliniska vårdvägar

Sök liknande artiklar

1. Behandlingsrekommendation. Diagnostik och behandling av kronisk hjärtsvikt. Information från Läkemedelsverket. 2006:7-87.
2. McMurray JJ, Adamopoulos S, Anker SD, et al. ESC Guidelines for the diagnosis and treatment of acute and chronic heart failure 2012: The Task Force for the Diagnosis and Treatment of Acute and Chronic Heart Failure 2012 of the European Society of Cardiology. Developed in collaboration with the Heart Failure Association (HFA) of the ESC. Eur Heart J. 2012;33:1787-847.
3. Cowie MR, Wood DA, Coats AJ, Thompson SG, Poole-Wilson PA, Suresh V, et al. Incidence and aetiology of heart failure; a population-based study. Eur Heart J 1999; 20:421-8.
4. Kannel WB. (2000) Vital epidemiologic clues in heart failure. J Clin Epidemiol 53: 229-35.
5. Cowie MR, Mosterd A, Wood DA, Deckers JW, Poole-Wilson PA, et al. (1997) The epidemiology of heart failure. Eur Heart J 18: 208-25.
6. Iung B, Baron G, Butchart EG, Delahaye F, Gohlke-Bärwolf C, Levang OW, et al. (2003) A prospective survey of patients with valvular heart disease in Europe: The Euro Heart Survey on valvular heart disease. Eur Heart J 24: 1231-43.
7. Maisel WH, Stevenson LW. (2003) Atrial fibrillation in heart failure: epidemiology, pathophysiology, and rationale for therapy. Am J Cardiol 91: 2D-8D.
8. Elliott P, Andersson B, Arbustini E, Bilinska Z, Cecchi F, Charron P, et al. (2008) Classification of the cardiomyopathies: a position statement from the European Society Of Cardiology Working Group on Myocardial and Pericardial Diseases. Eur Heart J 29: 270-6.
9. Lee DS, Gona P, Vasan RS, Larson MG, Benjamin EJ, Wang TJ, et al. (2009) Relation of disease pathogenesis and risk factors to heart failure with preserved or reduced ejection fraction: insights from the framingham heart study of the national heart, lung, and blood institute. Circulation 119: 3070-3077.
10. Mann DL. Pathophysiology of heart failure. I: Libby P, Bonow RO, Mann DL, Zipes DP. Braunwald’s Heart disease, 8th edition. Philadelphia: Saunders; 2008. p 541-560.
11. Remes J, Miettinen H, Reunanen A, Pyörälä K. (1991) Validity of clinical diagnosis of heart failure in primary health care. Eur Heart J 12: 315-21.
12. Wheeldon NM, MacDonald TM, Flucker CJ, McKendrick AD, McDevitt DG, Struthers AD. (1993) Echocardiography in chronic heart failure in the community. Q J Med 86: 17-23.
13. Ishmail AA, Wing S, Ferguson J, Hutchinson TA, Magder S, Flegel KM. (1987) Interobserver agreement by auscultation in the presence of a third heart sound in patients with congestive heart failure. Chest 91: 870-873.
14. Badgett RG, Mulrow CD, Otto PM, Ramirez G. (1996) How well can the chest radiograph diagnose left ventricular dysfunction? J Gen Intern Med 11: 625-34.
15. Cooper LT Jr, Berry GJ, Shabetai R. (1997) Idiopathic giant-cell myocarditis - natural history and treatment. N Engl J Med 336: 1860-6.
16. Cooper LT Jr. (2009) Myocarditis. N Engl J Med 360: 1526-38.
17. Felker GM, Thompson RE, Hare JM, Hruban RH, Clemetson DE, Howard DL, et al. (2000) Underlying causes and long-term survival in patients with initially unexplained cardiomyopathy. New Engl J Med 342: 1077-84.
18. Hedberg P, Magounakis T, Dubaniewicz W, Viklund J, Carlsson J. (2007) ”Brustet hjärta” eller takotsubo-kardiomyopati drabbar kvinnor i postmenopaus. Läkartidningen 104:3277-82.
19. Bhatia RS, Tu JV, Lee DS, Austin PC, Fang J, Haouzi A, et al. (2006) Outcome of heart failure with preserved ejection fraction in a population-based study. N Engl J Med 355:260-9.
20. Owan TE, Hodge DO, Herges RM, Jacobsen SJ, Roger VL, Redfield MM. (2006) Trends in prevalence and outcome of heart failure with preserved ejection fraction. N Engl J Med 355: 251-9.
21. Zile MR, Gaasch WH, Anand IS, Haass M, Little WC, Miller AB, et al. (2010) Mode of death in patients with heart failure and a preserved ejection fraction. Results from the Irbesartan in heart failure with preserved ejection fraction study (I-preserve) trial. Circulation 121: 1393-405.
22. Lee DS, Gona P, Albano I, Larson MG, Benjamin E, et al. (2011) A systematic assessment of causes of death after heart failure onset in the community: impact of age at death, time period, and left ventricular systolic dysfunction. Circ Heart Fail 4: 36-43.
23. Schrier RW. (1988) Pathogenesis of sodium and water retention in high-output and low-output cardiac failure, nephritic syndrome, cirrhosis, and pregnancy. N Engl J Med 319:1065-72.
24. Warren JV, Stead EA Jr. (1944) Fluid dynamics in chronic congestive heart failure. An interpretation of the mechanisms producing the edema, increased plasma volume and elevated venous pressure in certain patients with prolonged congestive failure. Arch Intern Med 73: 138-47.
25. Mant J, Doust J, Roalfe A, Barton P, Cowie MR, Glasziou P, et al. (2009) Systematic review and individual patient data meta-analysis of diagnosis of heart failure, with modeling of implications of different diagnostic strategies in primary care. Health Technol Assess 13: 1-207.
26. Johnston M, Collins SP, Storrow AB. (2007) The third heart sound for diagnosis of acute heart failure. Curr Heart Fail Rep 4: 164-168.
27. Marcus GM, Gerber IL, McKeown BH, Vessey JC, Jordan MV, et al. (2005) Association between phonocardiographic third and fourth heart sounds and objective measures of left ventricular function. JAMA 293: 2238-44.
28. Wang CS, FitzGerald JM, Schulzer M, Mak E, Ayas NT. Does this dyspneic patient in the emergency department have congestive heart failure? JAMA 294: 1944-56.
29. Badgett RG, Lucey CR, Mulrow CD. Can the clinical examination diagnose left-sided heart failure in adults? (1997) JAMA 277: 1712-9.
30. Warner Stevenson LW, Perloff JK. (1989) The limited reliability of physical signs for estimating hemodynamics in chronic heart failure. JAMA 261: 884-8.
31. Wang TJ, Larson MG, Levy D, Vasan RS, Leip EP, Wolf PA, et al. (2003) Temporal relations of atrial fibrillation and congestive heart failure and their joint influence on mortality: the Framingham Heart Study. Circulation 107: 2920-5.
32. van Kimmenade RR, Pinto YM, Bayes-Genis A, Lainchbury JG, Richards AM, Januzzi JL Jr. (2006) Usefulness of intermediate amino-terminal pro-brain natriuretic peptide concentrations for diagnosis and prognosis of acute heart failure. Am J Cardiol 98: 386-90.
33. Hildebrandt P, Collinson PO, Doughty RN, Fuat A, Gaze DC, Gustafsson F, et al. (2010) Age-dependent values of N-terminal pro-B-type natriuretic peptide are superior to a single cut-point for ruling out suspected systolic dysfunction in primary care. Eur Heart J 31: 1881-9.
34. O’Donoghue M, Braunwald E. (2010) Natriuretic peptides in heart failure: should therapy be guided by BNP levels? Nat Rev Cardiol 7: 13-20.
35. Edler I, Hertz CH. The use of the ultrasonic reflectoscope for the continuous recording of the movements of heart walls. Kungl Fysiografiska Sällskapets i Lund Förhandlingar 1954: 1-19.
36. Curtis JP, Sokol SI, Wang Y, Rathore SS, Ko DT, Jadbabaie F, et al. (2003) The association of left ventricular ejection fraction, mortality, and cause of death in stable outpatients with heart failure. J Am Coll Cardiol 42: 736-42.
37. Otterstad JE, Froeland G, St John Sutton M, Holme I. (1997) Accuracy and reproducibility of biplane two-dimensional echocardiographic measurements of left ventricular dimensions and function. Eur Heart J 18: 507-13.
38. Paulus WJ, Tschope C, Sanderson JE, Rusconi C, Flachskampf FA, Rademakers FE, et al. (2007) How to diagnose diastolic heart failure: a consensus statement on the diagnosis of heart failure with normal left ventricular ejection fraction by the Heart Failure and Echocardiography Associations of the European Society of Cardiology. Eur Heart J 28:2539-2550.
39. Le Jemtel TH, Padeletti M, Jelic S. (2007) Diagnostic and therapeutic challenges in patients with coexistent chronic obstructive pulmonary disease and chronic heart failure. J Am Coll Cardiol 49: 171-180.
40. Ravenscraft SA, Gross CR, Kubo SH, Olivari MT, Shumway SJ, Bolman RM, et al. (1993) Pulmonary function after successful heart transplantation. One year follow-up. Chest 103: 54-58.
41. Muzzarelli S, Ordovas K, Higgins CB. (2011) Cardiovascular MRI for the assessment of heart failure: focus on clinical management and prognosis. J Magn Reson Imaging 33:275-86.
42. Cooper LT, Baughman KL, Feldman AM, Frustaci A, Jessup M, Kuhl U, et al. (2007) The role of endomyocardial biopsy in the management of cardiovascular disease. Eur Heart J 28: 3076-93.
43. Mancini D, Lietz K. (2010) Selection of cardiac transplantation candidates in 2010. Circulation 122: 173-83.
44. Fleg JL, Lakatta EG. (1988) Role of muscle loss in the age-associated reduction in VO2 max. J Appl Physiol 65: 1147-51.